Dr. Ingo Potrykus, co-inventor of Golden Rice, discussed the potential of this genetically modified crop to combat vitamin A deficiency at KAUST's 2014 Winter Enrichment Program. Golden Rice, engineered to produce beta carotene, could prevent millions of deaths and cases of blindness annually in developing countries where rice is a staple. Regulatory hurdles for GMOs have stalled the distribution of Golden Rice, increasing development costs and delaying its availability to farmers. Why it matters: This highlights the potential of biotechnology developed and discussed in the GCC to address global health challenges, but also the regulatory and ethical considerations surrounding GMOs.
KAUST researchers collaborated to identify molecular pathways for plant biofortification of vitamin A. A KAUST group demonstrated high pressure conversion of carbon dioxide into useful products. Another team designed a biosensor using metal oxide transistors to detect glucose in saliva. Why it matters: These projects highlight KAUST's contributions to biotechnology, environmental sustainability, and healthcare through advanced materials and molecular techniques.
MBZUAI's BioMedIA lab, led by Mohammad Yaqub, is developing AI solutions for healthcare challenges in cardiology, pulmonology, and oncology using computer vision. Yaqub's previous research analyzed fetal ultrasound images to correlate bone development with maternal vitamin D levels. The lab is now applying image analysis to improve the treatment of head and neck cancer using PET and CT scans. Why it matters: This research demonstrates the potential of AI and computer vision to improve diagnostic accuracy and accessibility of healthcare in the region and beyond.
Dr. Andrew Bastawrous, CEO/co-founder of Peek, discussed his work on mobile eye clinics at KAUST. He developed Peek Acuity and Peek Retina, which turn smartphones into tools for detecting visual impairment. The technology uses smartphone screens and camera clip-ons to image inside the eye. Why it matters: This low-cost mobile ophthalmic tool has the potential to prevent and treat vision loss in underserved communities.
Dr. John Bedbrook of DiCE Molecules LLC spoke at KAUST about the challenges of feeding a growing population with increasingly stressed arable land. He noted the increasing demand for meat in emerging economies exacerbates the problem. Bedbrook emphasized the role of genetics and hybridization in improving crop yields and quality to address food security. Why it matters: Investments in agricultural biotechnology are crucial for the GCC region to enhance food security and reduce reliance on imports amid changing climate conditions.
MBZUAI Professor Fahad Khan is working on a unified theory of machine visual intelligence. His goal is to enable AI systems to better understand and function in complex, chaotic visual environments. The aim is to improve real-world applications like smart cities, personalized healthcare, and autonomous vehicles. Why it matters: This research could significantly advance AI's ability to perceive and interact with the real world, especially in challenging environments common in the developing world.
KAUST's Center for Desert Agriculture is holding an international conference on November 3-5, 2014, focusing on desert rhizosphere microbes for sustainable agriculture. Researchers aim to understand how plants survive in extreme conditions by studying microbes that help them tolerate heat, drought, and salt. They will explore genetic engineering and natural microbe usage to improve crop performance under heightened stress conditions. Why it matters: This research is critical for adapting agricultural systems to global warming and meeting future food production challenges in arid regions like the Middle East.
KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.